Table 3.

—Outcomes of Patients Hospitalized With AMI According to a History of COPD

	Total Study Population
Therapies/Outcomes	COPD Present, %	COPD Absent, %	OR (95% CI)
Outcomes
Atrial fibrillation	24.3	18.2a	1.14 (0.97-1.34)
Heart failure	52.5	34.8b	1.59 (1.37-1.83)
Cardiogenic shock	5.7	6.0	0.88 (0.66-1.18)
Stroke	1.7	1.7	0.83 (0.49-1.40)
In-hospital death	13.5	10.1b	1.25 (0.99-1.50)
30-d mortality	18.7	13.2a	1.31 (1.10-1.58)
Therapies
β-Blockers	78.2	89.6a	0.44 (0.35-0.50)
Anticoagulants	69.7	73.1	0.81 (0.69-0.95)
Lipid-lowering agents	52.9	59.2a	0.70 (0.60-0.82)
Calcium channel  blocker	32.9	23.8a	1.31 (1.13-1.52)
Cardiac catheterization	39.0	56.0a	0.56 (0.48-0.65)
PCI	23.0	36.0a	0.64 (0.54-0.77)
CABG	4.0	6.4c	0.46 (0.32-0.66)

Variables included in the model: COPD, age, sex, year of hospitalization, cardiovascular disease history (coronary artery disease, stroke, heart failure, diabetes, hypertension), renal failure, length of stay, ST-elevation MI. See Table 1 and 2 legends for expansion of abbreviations.

^aP < .001.

^bP < .01.

^cP = .051.